title: Hepatocellular carcinoma in a hepatitis C patient with sustained viral response and no fibrosis.
abstract: Hepatitis C poses a substantial global health burden. Three to five percent of individuals with liver cirrhosis secondary to hepatitis C will develop hepatocellular carcinoma. The development of hepatocellular carcinoma is closely associated with cirrhosis in hepatitis C infection, whereas in hepatitis B virus infection, hepatocellular carcinoma may occur in the absence of cirrhosis. Although uncommon, hepatocellular carcinoma has been reported in hepatitis C patients without cirrhosis and, in very rare cases, in the absence of active viral replication. We report the case of a 51-year-old patient with hepatitis C who developed hepatocellular carcinoma in the absence of fibrosis and after having achieved sustained virological response with combination peginterferon and ribavirin therapy seven years prior. The patient successfully underwent surgical resection, and histopathological examination of the resected tissue demonstrated a poorly-differentiated hepatocellular carcinoma in an otherwise unremarkable liver. The patient continues to do well and has no evidence of tumor recurrence 18 months post-operatively. This case raises question regarding the carcinogenesis of hepatocellular carcinoma as a sequela of chronic hepatitis C in noncirrhotic liver and moreover after achieving sustained virological response.
authors.affiliation: Department of Internal Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
authors.forename: James H
authors.initials: JH
authors.lastname: Tabibian
authors.forename: Carmen
authors.initials: C
authors.lastname: Landaverde
authors.forename: Julie
authors.initials: J
authors.lastname: Winn
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Geller
authors.forename: Nicholas N
authors.initials: NN
authors.lastname: Nissen
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000601:surgery / Q000821:virology*; D005260:Female; D006498:Hepatectomy; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000821:virology; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery / Q000821:virology*; D008875:Middle Aged; D012254:Ribavirin / Q000627:therapeutic use; D016896:Treatment Outcome; D019562:Viral Load; D014779:Virus Replication / Q000187:drug effects
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons